Sanofi Stock Euronext Paris
Stocks
SANNV
FR001400ED05
Pharmaceuticals
OTC Markets Traded| Market Cap | 92.83B 106B 85.66B 78.95B 149B 10,229B 152B 1,024B 403B 5,010B 399B 390B 17,246B | P/E 2026 * |
11.7x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 94.54B 87.15B 164B 11,290B 168B 1,130B 444B 5,530B 440B 431B 19,036B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.97x |
| Free-Float |
89% | Yield 2026 * |
5.5% | Yield 2027 * | 5.83% |
Last Transcript: Sanofi
| 1 day | -1.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | -7.74% | - | - | 106B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.27% | +0.54% | +28.13% | +55.82% | 397.23B | |
| Weighted average by Cap. | +0.16% | +0.02% | +37.75% | +81.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46.95B 53.73B 43.33B 39.94B 75.27B 5,174B 76.94B 518B 204B 2,534B 202B 197B 8,723B | 50.04B 57.26B 46.17B 42.56B 80.22B 5,514B 82B 552B 217B 2,701B 215B 210B 9,296B |
| Net income | 7.99B 9.14B 7.37B 6.8B 12.81B 881B 13.09B 88.13B 34.66B 431B 34.34B 33.58B 1,485B | 8.9B 10.19B 8.22B 7.57B 14.27B 981B 14.59B 98.19B 38.62B 480B 38.26B 37.42B 1,654B |
| Net Debt | 9.63B 11.02B 8.89B 8.19B 15.44B 1,061B 15.78B 106B 41.78B 520B 41.39B 40.48B 1,789B | 5.52B 6.32B 5.09B 4.69B 8.85B 608B 9.04B 60.88B 23.94B 298B 23.72B 23.2B 1,025B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
